Atlas Trials

Study to Assess the Safety and Efficacy of DERMASEAL for the Treatment of Split-Thickness Skin Graft Donor Site Wounds

Clinical trial NCT06134843 · UNKNOWN

Trial details

NCT number
NCT06134843
Sponsor
Hobart W. Harris
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Skin Graft Complications
Start date
2024-09-01
Primary completion
2025-01-31
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.